Finance

Lists
Why is 300683 down 2,94%?
Dive Deeper
300683:SHE
Wuhan Hiteck Biological Pharma Co Ltd
23,80 CNY
-2,94%
(-0,72) 1D
16 ოქტ, 15:04:58 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300683...
Open
24,86 CNY
High
25,68 CNY
Low
23,62 CNY
Mkt. cap
3,24 მლრდ.
Avg. vol.
6,29 მლნ.
Volume
9,01 მლნ.
52-wk high
50,68 CNY
52-wk low
22,37 CNY
EPS
-2,07 CNY
Shares outstanding
130,89 მლნ.
No. of employees
958
Open
24,86 CNY
High
25,68 CNY
Low
23,62 CNY
Mkt. cap
3,24 მლრდ.
Avg. vol.
6,29 მლნ.
Volume
9,01 მლნ.
52-wk high
50,68 CNY
52-wk low
22,37 CNY
EPS
-2,07 CNY
Shares outstanding
130,89 მლნ.
No. of employees
958
News stories
From web sources and news partners
Law360
Law360
·
39 წუთის წინ
Nasdaq Sued Over Delisting Of Social Media Co.
MarketBeat
MarketBeat
·
13 წუთის წინ
Billiontoone (NASDAQ:BLLN) CEO Sells $313,016.22 in Stock
Moomoo
Moomoo
·
17 წუთის წინ
28.2 Close
Seeking Alpha
Seeking Alpha
·
39 წუთის წინ
S&P 500 Snapshot: Stocks Slide Nearly 2% For The Week
About Wuhan Hiteck Biological Pharma Co Ltd
CEO-
Employees958
Founded8 აპრ. 1992
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
146,84 მლნ.
119,55 მლნ.
159,05 მლნ.
66,47 მლნ.
Cost of goods sold
79,88 მლნ.
78,74 მლნ.
97,87 მლნ.
53,09 მლნ.
Cost of revenue
79,88 მლნ.
78,74 მლნ.
97,87 მლნ.
53,09 მლნ.
Research and development expenses
19,60 მლნ.
21,91 მლნ.
19,43 მლნ.
19,95 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
75,67 მლნ.
72,55 მლნ.
60,07 მლნ.
56,77 მლნ.
Operating expense
83,83 მლნ.
115,96 მლნ.
77,22 მლნ.
84,95 მლნ.
Total operating expenses
163,70 მლნ.
194,71 მლნ.
175,09 მლნ.
138,04 მლნ.
Operating income
-16,87 მლნ.
-75,16 მლნ.
-16,05 მლნ.
-71,57 მლნ.
Other non operating income
-3,02 მლნ.
3,36 მლნ.
-103,60 ათ.
114,73 ათ.
EBT including unusual items
-127,52 მლნ.
-66,89 მლნ.
-26,83 მლნ.
-60,40 მლნ.
EBT excluding unusual items
-18,53 მლნ.
-62,83 მლნ.
-15,50 მლნ.
-70,17 მლნ.
Income tax expense
-6,84 მლნ.
7,65 მლნ.
-2,90 მლნ.
-4,44 მლნ.
Effective tax rate
5,36%
-11,44%
10,81%
7,35%
Other operating expenses
-6,81 მლნ.
10,42 მლნ.
-904,39 ათ.
4,52 მლნ.
Net income
-118,91 მლნ.
-73,17 მლნ.
-23,05 მლნ.
-55,66 მლნ.
Net profit margin
-80,98%
-61,21%
-14,49%
-83,74%
Earnings per share
-
-
-
-
Interest and investment income
1,71 მლნ.
9,29 მლნ.
920,58 ათ.
1,56 მლნ.
Interest expense
-322,55 ათ.
-319,50 ათ.
-266,56 ათ.
-258,59 ათ.
Net interest expenses
1,39 მლნ.
8,97 მლნ.
654,02 ათ.
1,30 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
4,85 მლნ.
-51,87 მლნ.
7,24 მლნ.
-49,78 მლნ.
Gain or loss from assets sale
-572,00
979,18 ათ.
-
2,30 მლნ.
AI content may include mistakes. Learn more
Google აპები